ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2026
Gut microbiota and ABC transporter pathway: potential links to the therapeutic efficacy of Shen-Ling-Bai-Zhu-San against antibiotic-associated diarrhea in juvenile rats.
Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundShen-Ling-Bai-Zhu-San (SLBZS) recorded in the Song Dynasty text "Tai Ping Hui Min He Ji Ju Fang," is traditionally used to "strengthen the spleen, eliminate dampness and stop diarrhea." making it a commonly used prescription for treating antibiotic-associated diarrhea (AAD). This study examined microbial and metabolite changes accompanying SLBZS treatment for AAD and analyzed their potential biological correlates.
methodsJuvenile rats were randomly assigned to control, model, and SLBZS groups. An antibiotic cocktail was administered orally to induce AAD, followed by SLBZS decoction treatment. Body weight and fecal characteristics were monitored. Gut microbiota and fecal metabolites were analyzed using 16 S rDNA sequencing and widely targeted metabolomics, respectively, with correlation analysis performed on the data.
resultsSLBZS significantly reduced diarrhea incidence and fecal consistency scores in AAD rats. Antibiotic gavage induced gut microbiota dysbiosis and metabolic disturbances. The abundances of Muribaculaceae, Tannerellaceae, Parabacteroides, and Parabacteroides distasonis were favorably modulated by SLBZS. Twenty-nine common differential fecal metabolites exhibited favorable regulation, with 11 metabolites enriched in the ABC transporter pathway. Correlation analysis revealed that seven metabolites significantly correlated with Parabacteroides distasonis, five of which culstered in the ABC transporter pathway.
conclusionsSLBZS treatment for AAD was associated with altered Parabacteroides distasonis abundance and ABC transporter pathway changes. These factors likely represent key biological targets of SLBZS therapy.
Indexed as
Identifiers
42711619What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.